Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.59 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.52 |
| ▸ | DRD2 | P14416 | 4/20 | 0.50 |
| ▸ | ADRA1A | P35348 | 4/20 | 0.50 |
| ▸ | DRD3 | P35462 | 4/20 | 0.50 |
| ▸ | FABP1 | P07148 | 1/20 | 0.50 |
| ▸ | FABP6 | P51161 | 1/20 | 0.50 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.50 |
| ▸ | TLR8 | Q9NR97 | 2/20 | 0.47 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.47 |
| ▸ | ITGAV | P06756 | 1/20 | 0.47 |
| ▸ | SOAT1 | P35610 | 2/20 | 0.47 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30449687 | 1.00 | CYP2C19 (0.59) | CYP2C19ALOX12CYP1A2SMN1; SMN2HTT | |
| SCHEMBL7447683 | 0.98 | ALOX12 (0.60) | CYP2C19ALOX12CYP1A2SMN1; SMN2HTT | |
| SCHEMBL30205633 | 0.98 | ALOX12 (0.60) | CYP2C19ALOX12CYP1A2SMN1; SMN2HTT | |
| SCHEMBL11124152 | 0.98 | ALOX12 (0.60) | CYP2C19ALOX12CYP1A2SMN1; SMN2HTT | |
| SCHEMBL10607875 | 0.98 | ALOX12 (0.60) | CYP2C19ALOX12CYP1A2SMN1; SMN2HTT | |
| SCHEMBL1573818 | 0.98 | ALOX12 (0.60) | CYP2C19ALOX12CYP1A2SMN1; SMN2HTT | |
| SCHEMBL31066872 | 0.98 | ALOX12 (0.60) | CYP2C19ALOX12CYP1A2SMN1; SMN2HTT | |
| SCHEMBL31066860 | 0.98 | ALOX12 (0.60) | CYP2C19ALOX12CYP1A2SMN1; SMN2HTT | |
| SCHEMBL10606557 | 0.98 | ALOX12 (0.60) | CYP2C19ALOX12CYP1A2SMN1; SMN2HTT | |
| Phosphine SCHEMBL27777792 | 0.98 | CYP2C19 (0.57) | CYP2C19ALOX12CYP1A2SMN1; SMN2HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 249 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8354097-B2 | Cosmetic composition forming after application a supramolecular polymer | L'OREAL (FR) | 2013-01-15 | — | — | US | claimed |
| US-20120027698-A9 | COSMETIC AND/OR PHARMACEUTICAL COMPOSITION COMPRISING AT LEAST ONE COPOLYMER COMPRISING AT LEAST ONE IONIZABLE GROUP, AND COSMETIC TREATMENT PROCESS | L'OREAL S.A. | 2012-02-02 | — | — | US | claimed |
| US-7862805-B2 | Cosmetic composition forming after application a supramolecular polymer | L'OREAL (FR) | 2011-01-04 | — | — | US | claimed |
| US-20100278764-A1 | COSMETIC AND/OR PHARMACEUTICAL COMPOSITION COMPRISING AT LEAST ONE COPOLYMER COMPRISING AT LEAST ONE IONIZABLE GROUP, AND COSMETIC TREATMENT PROCESS | L'OREAL S.A. | 2010-11-04 | — | — | US | claimed |
| US-20100242188-A1 | COMPOSITION FOR COLOURING KERATINOUS MATERIAL USING A SUPRA-MOLECULAR COLOURING SYSTEM | L'OREAL S.A. (FR) | 2010-09-30 | — | — | US | claimed |
| US-20100247466-A1 | COSMETIC COMPOSITION FORMING AFTER APPLICATION A SUPRAMOLECULAR POLYMER | L'OREAL (FR) | 2010-09-30 | — | — | US | claimed |
| EP-2083791-A2 | COMPOSITION FOR COLOURING KERATINOUS MATERIAL USING A SUPRA-MOLECULAR COLOURING SYSTEM | L'Oreal (FR) | 2009-08-05 | — | — | EP | claimed |
| WO-2008059125-A2 | COMPOSITION FOR COLOURING KERATINOUS MATERIAL USING A SUPRA-MOLECULAR COLOURING SYSTEM | L'OREAL (FR) | 2008-05-22 | — | — | WO | claimed |
| WO-2008039863-A2 | COMPOSITION COMPRISING A MELANOCORTIN RECEPTOR (MCR) MODULATING AGENT ALONE OR IN COMBINATION WITH A SECOND NEUROGENIC AGENT FOR TREATING NERVOUS SYSTEM DISORDERS | BRAINCELLS, INC. (US) | 2008-04-03 | — | — | WO | claimed |
| WO-2008022467-A1 | 2-SUBSTITUTED AZAIN DOLES AND 2 SUBSTITUTED THIENOPYRROLES, THEIR PRECURSORS AND NOVEL PROCESSES FOR THE PREPARATION THEREOF | LAUTENS MARK (CA) | 2008-02-28 | — | — | WO | claimed |
| US-20040010864-A1 | Method for treating human keratin fibers with organomodified metallic particles | L'OREAL (FR) | 2004-01-22 | — | — | US | claimed |
| EP-0530524-B1 | Method of producing 2-amino-3-nitro-5-halogenopyridine | ICHIKAWA GOSEI KAGAKU KK (JP) | 2003-02-05 | — | — | EP | claimed |
| WO-2002098377-A1 | COSMETIC COMPOSITION FORMING AFTER APPLICATION A SUPRAMOLECULAR POLYMER | L'OREAL (FR) | 2002-12-12 | — | — | WO | claimed |
| EP-1221444-A1 | FUSED IMIDAZOLE COMPOUNDS AND REMEDIES FOR DIABETES MELLITUS | Eisai Co., Ltd. (JP) | 2002-07-10 | — | — | EP | claimed |
| US-5998594-A | CHROMOGENIC COMPOUND BEING CHARACTERIZED BY THE PROPERTY OF PRODUCING A REVERSIBLE COLOR CHANGE RESPONSIVE ON BINDING A TARGET SUBSTRATE TO SAID RECEPTOR. | UNIVERSITY OF PITTSBURGH OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 1999-12-07 | — | — | US | claimed |
| US-5453512-A | Bromination of acylaminopyridine with 2-acylaminopyridinium hydorbromide | ICHIKAWA GOSEI CHEMICAL CO., LTD. (JP) | 1995-09-26 | — | — | US | claimed |
| US-5290943-A | Halogenation of pyridine compound | ICHIKAWA GOSEI CHEMICAL CO., LTD. (JP) | 1994-03-01 | — | — | US | claimed |
| EP-0530524-A1 | Method of producing 2-amino-3-nitro-5-halogenopyridine | ICHIKAWA GOSEI CHEMICAL CO., LTD. (JP) | 1993-03-10 | — | — | EP | claimed |
| WO-1991017979-A1 | PROCESS FOR THE PREPARATION OF 2-N-ACYLAMINOPYRIDINES AND 2-AMINOPYRIDINES FROM 5-OXOALKANENITRILE OXIMES | DSM N.V. (NL) | 1991-11-28 | — | — | WO | claimed |
| US-4914077-A | GOOD HUE AND STABILITY | EASTMAN KODAK COMPANY (US) | 1990-04-03 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100242188-A1 | COMPOSITION FOR COLOURING KERATINOUS MATERIAL USING A SUPRA-MOLECULAR COLOURING SYSTEM | KRT18, S100A6, IK | CYP2C19 3627/4885ALOX12 3964/4885CYP1A2 3076/4885 |
| US-20120027698-A9 | COSMETIC AND/OR PHARMACEUTICAL COMPOSITION COMPRISING AT LEAST ONE COPOLYMER COMPRISING AT LEAST ONE IONIZABLE GROUP, AND COSMETIC TREATMENT PROCESS | KRT18, DSG1, DSC1 | CYP2C19 1153/4885ALOX12 2343/4885CYP1A2 3450/4885 |
| US-20100278764-A1 | COSMETIC AND/OR PHARMACEUTICAL COMPOSITION COMPRISING AT LEAST ONE COPOLYMER COMPRISING AT LEAST ONE IONIZABLE GROUP, AND COSMETIC TREATMENT PROCESS | KRT18, DSG1, DSC1 | CYP2C19 1153/4885ALOX12 2343/4885CYP1A2 3450/4885 |
| US-20100247466-A1 | COSMETIC COMPOSITION FORMING AFTER APPLICATION A SUPRAMOLECULAR POLYMER | KRT18, CUTA, DSG1 | CYP2C19 4728/4885ALOX12 4082/4885CYP1A2 4810/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.